These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8571954)

  • 1. Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.
    Heidemann BE; Koopal C; Baass A; Defesche JC; Zuurbier L; Mulder MT; Roeters van Lennep JE; Riksen NP; Boot C; Marais AD; Visseren FLJ
    Clin Genet; 2022 Oct; 102(4):253-261. PubMed ID: 35781703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.
    Sfyri P; Matsakas A
    J Biomed Sci; 2017 Jul; 24(1):42. PubMed ID: 28688452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable phenotypic expression of nonsense mutation p.Thr5* in the APOE gene.
    Leren TP; Strøm TB; Berge KE
    Mol Genet Metab Rep; 2016 Dec; 9():67-70. PubMed ID: 27830118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of apolipoprotein E in neurodegenerative diseases.
    Giau VV; Bagyinszky E; An SS; Kim SY
    Neuropsychiatr Dis Treat; 2015; 11():1723-37. PubMed ID: 26213471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.
    Merscher S; Pedigo CE; Mendez AJ
    Front Endocrinol (Lausanne); 2014; 5():169. PubMed ID: 25352833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function.
    Mak AC; Pullinger CR; Tang LF; Wong JS; Deo RC; Schwarz JM; Gugliucci A; Movsesyan I; Ishida BY; Chu C; Poon A; Kim P; Stock EO; Schaefer EJ; Asztalos BF; Castellano JM; Wyss-Coray T; Duncan JL; Miller BL; Kane JP; Kwok PY; Malloy MJ
    JAMA Neurol; 2014 Oct; 71(10):1228-36. PubMed ID: 25111166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE-dependent plasticity in Alzheimer's disease.
    Teter B
    J Mol Neurosci; 2004; 23(3):167-79. PubMed ID: 15181245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.
    Zhu Y; Bellosta S; Langer C; Bernini F; Pitas RE; Mahley RW; Assmann G; von Eckardstein A
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7585-90. PubMed ID: 9636193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.
    Tsukamoto K; Smith P; Glick JM; Rader DJ
    J Clin Invest; 1997 Jul; 100(1):107-14. PubMed ID: 9202062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe xanthomatosis associated with familial apolipoprotein E deficiency.
    Feussner G
    J Clin Pathol; 1996 Dec; 49(12):985-9. PubMed ID: 9038735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of type III hyperlipoproteinemia in Germany.
    Feussner G; Feussner V; Hoffmann MM; Lohrmann J; Wieland H; März W
    Hum Mutat; 1998; 11(6):417-23. PubMed ID: 9603433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apolipoprotein E].
    Yamamura T
    Nihon Rinsho; 1994 Dec; 52(12):3124-32. PubMed ID: 7853700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III hyperlipoproteinemia in a child with hemolytic uremic syndrome.
    Feussner G; Wingen AM; Ziegler R
    Metabolism; 1990 Nov; 39(11):1196-9. PubMed ID: 2233282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Gröne HJ; Lohmer S; Wohlfeil S
    Am J Hum Genet; 1996 Feb; 58(2):281-91. PubMed ID: 8571954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
    Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
    Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.